findmyKOL

Bruce Bode, MD

Enriched profile

CEO and President, Atlanta Diabetes Associates; Clinical Associate Professor, Department of Medicine, Emory University School of Medicine · Atlanta Diabetes Associates

ORCIDNPI
Region🇺🇸 Atlanta, GA · Southeast · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusDiabetes Management and Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Bruce Bode is CEO and President, Atlanta Diabetes Associates; Clinical Associate Professor, Department of Medicine, Emory University School of Medicine at Atlanta Diabetes Associates. OpenAlex indexes 373 publications with 27,566 citations (h-index 84); ClinicalTrials.gov lists 18 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Bruce W. Bode, MD, is CEO and President, Atlanta Diabetes Associates. The public record shows 373 publications with 27,566 citations (h-index 84), centered on Diabetes Management and Research, Diabetes Treatment and Management, Pancreatic function and diabetes. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 71 companies.

  • Most recent indexed publication: 2023 · Annals of internal medicine
  • Top research focus: Diabetes Management and Research
  • 18 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 71 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 1 Diabetes13 trialsType 2 Diabetes8 trialsHypoglycemia3 trialsHyperglycemia1 trial

Research focus

OpenAlex concept fingerprint
Diabetes Management and ResearchDiabetes Treatment and ManagementPancreatic function and diabetesHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes and associated disorders

Drugs & molecules

across trials, industry payments and publications
Rybelsusgeneric · SemaglutideClinical trialsIndustry payments374Publications1Mounjarogeneric · TirzepatideClinical trialsIndustry payments80Publications1Tzieldgeneric · TeplizumabClinical trialsIndustry payments60Publications1

Works with

trial sponsors and companies reporting payments
Insulet CorporationClinical trials1Industry payments28Novo Nordisk IncClinical trialsIndustry payments312Lilly USA, LLCClinical trialsIndustry payments307

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
373publications

Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.

27,566citations

Total citations across indexed works.

84h-index

Hirsch index (OpenAlex). i10-index 191.

Clinical & industry

trials, payments and federal funding
18clinical trials

Investigator role on registered studies.

View trials
71companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

71 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    54.9%
    RANK Ligand Inhibitor54.6%
    Denosumab100%
    Part B, office-administered42 patients
    Xanthine oxidase inhibitor0.3%
    Allopurinol100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    23.8%
    Insulin Analog10.8%
    Tresiba Flextouch U-10017%Humalog11%Novolog Flexpen11%Novolog10%Lantus Solostar9%Humalog Kwikpen U-1009%Tresiba Flextouch U-2006%Fiasp Flextouch5%Insulin Lispro4%Insulin Lispro Kwikpen U-1003%Fiasp3%Humalog Kwikpen U-2003%Basaglar Kwikpen U-1002%Soliqua 100-332%Toujeo Max Solostar2%Toujeo Solostar2%
    Part D<11 patients
    GLP-1 receptor agonist5.5%
    Ozempic78%Mounjaro17%Trulicity5%
    Part D<11 patients
  • Cardiovascular

    11.3%
    Statin5.1%
    Atorvastatin Calcium43%Rosuvastatin Calcium39%Simvastatin14%Pravastatin Sodium5%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)1.8%
    Losartan Potassium80%Irbesartan-Hydrochlorothiazide12%Losartan-Hydrochlorothiazide9%
    Part D<11 patients
6 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)3.7% facility · 96.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 27 Aug 2026

53 congress contributions (2018–2026) across ADA, ENDO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Trang T. Ly45Bruce A. Buckingham43Satish K. Garg42

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/bruce-bode-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/bruce-bode-b5ab726

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/scientific-contributions/Bruce-Bode-39169841

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    diabetesincontrol.com/current-interview-dr-bruce-bode

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →diabetesincontrol.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
3 more roles behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Clinical Associate Professor

    Department of Medicine, Emory University School of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →atlantadiabetes.com
  • Affiliated physician

    Emory Saint Joseph's Hospital and Piedmont Atlanta Hospital

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.